Data on SOPHIA Trial in HER+ Metastatic Breast Cancer

Data on SOPHIA Trial in HER+ Metastatic Breast Cancer

obr

1 year
94 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Neelima Denduluri MD, Associate Professor, US Oncology Research, Virginia Cancer Specialists explains the results from the SOPHIA trial, a phase III study of chemotherapy plus margetuximab or trastuzumab in HER+ metastatic breast cancer.
Up Next Autoplay